I now have comprehensive material from multiple authoritative textbooks. Let me compile the full, exam-ready answer.
DWARFISM - Complete Study Guide for MUHS PG Medicine Theory Exam
QUICK DEFINITION
Dwarfism is defined as an adult height of less than 147 cm (4 ft 10 in). It results from a heterogeneous group of disorders affecting skeletal growth, endocrine function, or metabolic processes.
- Campbell's Operative Orthopaedics 15th Ed 2026
- Adams and Victor's Principles of Neurology, 12th Ed
CLASSIFICATION
A. By Body Proportions
| Type | Description | Examples |
|---|
| Proportionate dwarfism | Symmetric reduction in both trunk AND limb length; body proportions normal | GH deficiency, hypothyroidism, malnutrition, mucopolysaccharidoses |
| Disproportionate dwarfism | Selective shortening of trunk or limbs | See below |
Disproportionate dwarfism - subtypes:
-
Short-trunk variety - trunk shorter relative to limbs
- Example: Kniest syndrome (spondyloepiphyseal dysplasia)
-
Short-limb variety - limbs disproportionately short; trunk relatively normal
- Example: Achondroplasia, diastrophic dysplasia
- Short-limb dwarfism is further subclassified by which segment is short:
- Rhizomelic - proximal limb (humerus/femur) is short
- Mesomelic - middle segment (radius-ulna/tibia-fibula) is short
- Acromelic - distal segment (hands/feet) is short
- Miller's Review of Orthopaedics 9th Ed
CAUSES / ETIOLOGY
1. Endocrine Causes (Proportionate)
| Condition | Mechanism |
|---|
| GH deficiency (panhypopituitarism) | Most common cause of proportionate dwarfism |
| Hypothyroidism | Impaired GH secretion and target action |
| Cushing's syndrome | Excess glucocorticoids suppress growth |
| Precocious puberty | Early epiphyseal fusion |
| Diabetes mellitus (poorly controlled) | Mauriac syndrome |
2. Genetic / Skeletal Dysplasias (Disproportionate)
| Condition | Inheritance | Mutation | Key Feature |
|---|
| Achondroplasia | AD | FGFR3 (gain-of-function) | Most common skeletal dysplasia |
| Thanatophoric dysplasia | Sporadic | FGFR3 (more severe gain-of-function) | Most common LETHAL dwarfism |
| Diastrophic dwarfism | AR | SLC26A2 gene | Multiple joint contractures |
| Spondyloepiphyseal dysplasia | AD/XL | COL2A1 | Short trunk |
| Osteogenesis imperfecta | AD | COL1A1/COL1A2 | Fragile bones + blue sclerae |
3. Metabolic / Nutritional
- Mucopolysaccharidoses (storage disorders) - proportionate dwarfism
- Nutritional dwarfism (malnutrition, celiac disease, Crohn's disease)
- Renal osteodystrophy
4. Psychosocial Dwarfism
- Also called Kaspar-Hauser syndrome, maternal deprivation syndrome, or abuse dwarfism
- Growth retardation from emotional/psychological neglect
- Associated with retarded bone age and osteopenia
- Reversible with change in environment
- Brogdon's Forensic Radiology
5. Chromosomal / Syndromic
- Turner syndrome (45,X0) - short stature, gonadal dysgenesis
- Down syndrome (Trisomy 21)
- Russell-Silver syndrome - prenatal onset short stature, hemihypertrophy, craniofacial dysostosis
- Seckel (bird-headed) dwarfism - microcephaly, beaked nose, severe cognitive impairment (mutation in RAD3-related protein)
DETAILED PATHOPHYSIOLOGY
A. GH Deficiency Dwarfism (Pituitary Dwarfism)
The GH - IGF-1 axis:
Hypothalamus (GHRH)
↓
Anterior Pituitary (GH)
↓
Liver (IGF-1 / Somatomedin-C)
↓
Bone epiphyseal plates → Linear growth
Defects at any level cause dwarfism:
- Decreased GHRH (hypothalamic dysfunction)
- Primary GH deficiency (pituitary)
- Failure to generate IGF-1 (liver)
- GH receptor defects or IGF-1 receptor defects
Clinical features of GH deficiency dwarfism:
-
Proportionate short stature
-
Body proportions normal
-
Mild obesity (lack of fat mobilization)
-
Delayed puberty
-
No sexual development in 2/3 of patients; 1/3 do mature sexually
-
Normal intelligence
-
Delayed bone age
-
Guyton & Hall Textbook of Medical Physiology; Costanzo Physiology 7th Ed
B. Laron Dwarfism (GH Resistance)
- GH levels are elevated (not deficient)
- GH receptors are defective - cannot generate IGF-1
- Treatment with exogenous GH is INEFFECTIVE
- Treatment requires recombinant IGF-1
- Costanzo Physiology 7th Ed
C. Achondroplasia (Most Common Skeletal Dysplasia)
Gene: FGFR3 (fibroblast growth factor receptor 3), located on short arm of chromosome 4
Mutation: Gain-of-function - FGFR3 is constitutively active, causing pathologic suppression of endochondral cartilage growth
Inheritance: Autosomal dominant; ~90% are new mutations occurring almost exclusively on the paternal allele
Pathology: Normal membranous bone formation; defective endochondral ossification (affects long bones but not skull vault)
Clinical Features:
- Disproportionate short stature (limbs << trunk)
- Rhizomelic shortening (proximal limb segments most affected)
- Enlarged head with frontal bossing
- Depression at root of nose (saddle nose)
- Relatively normal trunk
- Normal intelligence
- Normal lifespan (usually)
- Foramen magnum narrowing - can cause spinal cord compression, sleep apnea
- Lumbar spinal stenosis - claudication and leg symptoms in adults
- Trident hand - fingers appear to diverge in three groups
Radiology:
-
Short, wide long bones
-
Champagne glass pelvis (narrow sacroiliac notch)
-
Bullet-shaped vertebrae
-
Decreasing interpedicular distance from L1 to L5 (reversed in normal)
-
Robbins & Kumar Basic Pathology; Bailey and Love's Surgery 28th Ed; Adams & Victor's Neurology
D. Thanatophoric Dysplasia
- Most common lethal form of dwarfism
- Also FGFR3 gain-of-function mutation, but more severe than achondroplasia
- Incidence: 1 in 20,000 live births
- Severe limb shortening, frontal bossing, macrocephaly
- Small chest cavity → respiratory insufficiency → death at birth or soon after
- Robbins & Kumar Basic Pathology
INVESTIGATIONS
For Proportionate Short Stature (Endocrine Work-Up)
- Bone age (X-ray wrist) - delayed in GH deficiency, hypothyroidism; advanced in precocious puberty
- Serum IGF-1 (Somatomedin-C) - best screening test for GH deficiency (stable, not pulsatile)
- Serum IGFBP-3 - low in GH deficiency
- GH stimulation tests (definitive):
- Insulin tolerance test (gold standard)
- Arginine stimulation
- Clonidine stimulation
- L-DOPA stimulation
- Thyroid function tests (TSH, free T4)
- Karyotype - in girls to rule out Turner syndrome
- MRI pituitary - to look for craniopharyngioma, tumors
- Serum cortisol - to rule out Cushing's
- IGF-1 generation test - if Laron syndrome suspected (high GH, low IGF-1, no response to exogenous GH)
For Disproportionate Short Stature (Skeletal Dysplasia Work-Up)
- Skeletal survey X-rays (whole body)
- Molecular genetic testing (FGFR3 for achondroplasia)
- MRI spine/foramen magnum (in achondroplasia - assess stenosis)
- CT pelvis/femur (if arthroplasty planned)
TREATMENT
Pituitary (GH Deficiency) Dwarfism
| Treatment | Detail |
|---|
| Recombinant human GH (somatropin) | Given daily SC injections; effective only if given before epiphyseal fusion; pure GH deficiency can be completely cured if treated early |
| Dose | 0.025-0.05 mg/kg/day SC |
| Response | Best in first year; continue until final height achieved |
| GH is species-specific | Animal GH does NOT work in humans; must use human recombinant GH |
| Laron dwarfism | Exogenous GH ineffective; treat with recombinant IGF-1 (mecasermin) |
- Guyton & Hall; Lippincott Illustrated Reviews Pharmacology; Katzung Pharmacology 16th Ed
GH is approved for:
- GH deficiency
- Turner syndrome
- Prader-Willi syndrome
- Chronic renal insufficiency (children)
- Small for gestational age (SGA)
- Idiopathic short stature (ISS)
Achondroplasia
- No cure currently
- Vosoritide (CNP analog, C-type natriuretic peptide) - recently approved to increase height velocity in children with achondroplasia
- Limb lengthening procedures (Ilizarov technique) used in some centers
- Foramen magnum decompression if symptomatic stenosis
- Spinal stenosis management
Hypothyroid Dwarfism
- Early thyroxine replacement (irreversible cognitive damage if untreated)
IMPORTANT EPONYMS & SPECIAL TYPES
| Eponym | Description |
|---|
| Laron dwarfism | GH resistance - high GH, low IGF-1, defective GH receptor |
| Seckel syndrome | Nanocephalic (bird-headed) dwarfism; microcephaly, beaked nose, severe mental retardation |
| Russell-Silver syndrome | Prenatal short stature, hemihypertrophy, craniofacial dysostosis |
| Psychosocial dwarfism | Kaspar-Hauser syndrome; emotional deprivation; reversible |
| Diastrophic dwarfism | AR, SLC26A2; multiple joint contractures; high scoliosis rate (88%) |
| Thanatophoric dwarfism | Most common lethal form; FGFR3; dies at/soon after birth |
HIGH-YIELD MNEMONICS
Causes of SHORT stature (MUTCD):
- M - Metabolic / nutritional
- U - Unknown (constitutional)
- T - Turner syndrome / chromosomal
- C - Chronic illness (renal, GI, cardiac)
- D - Dysmorphic syndromes / Dysplasias / Deficiency of GH
Short-limb segments (RMA):
- Rhizomelic = pRoximal (e.g., achondroplasia)
- Mesomelic = Middle
- Acromelic = distal (Acral)
EXAM-FORMAT WRITTEN ANSWER
Q. Write a short note on Dwarfism.
(This is a model answer for MUHS MD Medicine theory - 10 marks)
DEFINITION
Dwarfism is defined as a height of less than 147 cm (4 feet 10 inches) in an adult. It encompasses a wide spectrum of disorders affecting bone growth, endocrine function, and metabolism.
CLASSIFICATION
Dwarfism is broadly classified as:
I. Proportionate dwarfism: Symmetric reduction in both trunk and limb length with normal body proportions. Causes include GH deficiency, hypothyroidism, malnutrition, and mucopolysaccharidoses.
II. Disproportionate dwarfism:
- Short-trunk variety: e.g., spondyloepiphyseal dysplasia (Kniest syndrome)
- Short-limb variety: e.g., achondroplasia, diastrophic dwarfism
- Further subclassified as rhizomelic (proximal), mesomelic (middle), or acromelic (distal)
CAUSES
- Endocrine: GH deficiency (panhypopituitarism), Laron dwarfism (GH resistance), hypothyroidism, Cushing's syndrome, precocious puberty
- Skeletal dysplasias: Achondroplasia (FGFR3 gain-of-function mutation, AD), thanatophoric dysplasia (most common lethal form), diastrophic dwarfism (AR), osteogenesis imperfecta
- Chromosomal: Turner syndrome (45,X0), Down syndrome, Russell-Silver syndrome
- Nutritional: Malnutrition, celiac disease, inflammatory bowel disease
- Psychosocial: Deprivation/Kaspar-Hauser syndrome - reversible with treatment
- Constitutional: Familial short stature, constitutional delay of growth and puberty
PATHOPHYSIOLOGY
GH Deficiency (most common endocrine cause): The hypothalamic-pituitary-IGF-1 axis is disrupted at any level. GH acts via IGF-1 (somatomedin-C) produced in the liver to stimulate epiphyseal plate chondrocyte proliferation. Defects in GHRH, GH secretion, or IGF-1 generation all result in proportionate short stature with delayed bone age.
Achondroplasia: A gain-of-function mutation in FGFR3 gene (chromosome 4p) causes constitutive receptor activation, which pathologically suppresses endochondral ossification. 90% are new mutations occurring on the paternal allele. Results in rhizomelic short-limb dwarfism with normal membranous bone (skull, clavicle unaffected).
CLINICAL FEATURES
GH Deficiency: Proportionate short stature, delayed bone age, mild obesity, delayed puberty, infantile facies, high-pitched voice, normal intelligence
Achondroplasia: Disproportionate short stature with rhizomelic limb shortening, frontal bossing, saddle nose (depressed nasal bridge), relative trunk preservation, trident hand, normal intelligence, foramen magnum stenosis, lumbar spinal stenosis
INVESTIGATIONS
- Bone age X-ray (wrist)
- Serum IGF-1 and IGFBP-3 (screening for GH deficiency)
- GH stimulation tests (insulin tolerance test - gold standard)
- Thyroid function tests (TSH, free T4)
- Karyotype (girls - to rule out Turner syndrome)
- MRI pituitary (rule out craniopharyngioma)
- Skeletal survey X-rays (for skeletal dysplasias)
- Molecular genetic testing (FGFR3 in achondroplasia)
TREATMENT
GH deficiency: Recombinant human GH (somatropin) SC daily - most effective before epiphyseal fusion; pure GH deficiency can be completely cured if treated early
Laron dwarfism (GH resistance): Recombinant IGF-1 (mecasermin) - exogenous GH is ineffective as GH receptors are defective
Hypothyroidism: Early thyroxine replacement
Achondroplasia: Vosoritide (CNP analog) for children; limb lengthening (Ilizarov technique); foramen magnum/spinal canal decompression for neurological complications
Psychosocial dwarfism: Change of environment and psychosocial rehabilitation - leads to catch-up growth
COMPLICATIONS
- Foramen magnum stenosis (achondroplasia) - sleep apnea, sudden death, quadriplegia
- Lumbar spinal stenosis - claudication
- Premature osteoarthritis of hip
- Scoliosis (especially in diastrophic dwarfism - 88%)
- Psychological and social morbidity
SOURCES
- Guyton & Hall Textbook of Medical Physiology, p. 924-925
- Costanzo Physiology 7th Ed, p. (GH Pathophysiology section)
- Robbins & Kumar Basic Pathology (Achondroplasia, Thanatophoric Dysplasia)
- Adams and Victor's Principles of Neurology 12th Ed, p. 1016
- Bailey and Love's Short Practice of Surgery 28th Ed
- Campbell's Operative Orthopaedics 15th Ed 2026, p. 290
- Miller's Review of Orthopaedics 9th Ed
Key exam points to remember:
- Achondroplasia = most common skeletal dysplasia; FGFR3 gain-of-function; AD; 90% new mutations on paternal allele
- Thanatophoric dysplasia = most common LETHAL dwarfism; also FGFR3 but more severe
- Laron dwarfism = high GH + low IGF-1; GH receptor mutation; treat with IGF-1 not GH
- Psychosocial dwarfism = reversible with change in environment
- GH is species-specific - must use recombinant human GH
- Diastrophic dwarfism = AR; scoliosis in 88%
- Short-limb segments: Rhizomelic (proximal) > Mesomelic > Acromelic